DUBLIN–(BUSINESS WIRE)–The “Protein A Resin Market Research Report: By Source, Matrix, Application, End User – Industry Size, Share, Trends and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
The major protein A resin market drivers are the increasing geriatric population, prevalence of chronic diseases, funding for protein research, and need to meet the need for therapies for various conditions. The market revenue is projected to surge to $1,020.7 million by 2030, from $486.4 million in 2019, at a 7.0% CAGR during the forecast period (2019-2030). Protein A resin is used as a separation medium during purification processes, such immunoprecipitation and chromatography. It separates biochemical mixtures based on the enzyme-substrate, antigen-antibody, and receptor-nucleic acid interactions.
- Bio-Works Technologies AB
- Amikozen Co. Ltd.
- Bio-Rad Laboratories Inc.
- Expedeon AG
- Thermo Fisher Scientific Inc.
- GenScript Biotech Corporation
- Merck KGaA
- Tosoh Corporation
- Repligen Corporation
- Novasep Holding SAS
- Purolite Corporation
- Kaneka Corporation
General Electric Company
Based on source, the protein A resin market is bifurcated into natural and recombinant, of which the recombinant bifurcation would display the higher CAGR, of 7.5%, during the forecast period. This is because recombinant protein A resins are heavily used during the production of monoclonal antibodies (mAb). Earlier, pharmaceutical companies did not pursue mAbs, owing to their stability, size, degradation rate, and delivery limitations. But, with increasing funding and focus of private and public institutions on protein-based research, the development of mAbs is picking up pace.
Across the world, the need for effective treatments for metabolic diseases, cardiovascular diseases, infectious diseases, and cancer is highly unmet. This is promoting the development of monoclonal antibodies, as they can function similar to the mediators involved in pathological processes. Additionally, mAbs and other therapeutic proteins are less toxic, highly effective and potent, safe, tolerable, selective, and chemically and biologically diverse, and they also do not accumulate much on tissues. Therefore, with the increase in the research and development (R&D) for mAbs, the usage of protein A resin would rise.
One of the primary reasons behind the rising demand for monoclonal antibodies is the increasing incidence of chronic diseases. mAbs display a suitable pharmacokinetic profile, their solubility can be customized, and they also have a lesser chance of inducing an immune response, which is essential for the treatment to work. The diseases caused by hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV) are increasing in prevalence, due to the low accessibility of healthcare in developing nations.
Key Topics Covered:
1. Research Background
2. Research Methodology
3. Executive Summary
4.1 Definition of Market Segments
4.1.1 By Source
4.1.2 By Matrix
4.1.3 By Application
4.1.4 By End User
4.2 Market Dynamics
22.214.171.124 Increasing number of collaborations and agreements
126.96.36.199 Evolution of the market with product launches
188.8.131.52 Increasing research activities to address unmet medical needs in various therapeutic areas
184.108.40.206 Surging burden of chronic diseases
220.127.116.11 Rising investment and funding for protein-based research
18.104.22.168 Growing geriatric population
22.214.171.124 Impact analysis of drivers on market forecast
126.96.36.199 Lack of updated regulatory standards
188.8.131.52 Contamination issues during protein A synthesis and high capital requirements for drug development
184.108.40.206 Complex nature of protein A chromatography process
220.127.116.11 Impact analysis of restraints on market forecast
18.104.22.168 Emerging markets in the APAC region
4.3 Porter’s Five Forces Analysis
5. Global Market Size and Forecast
5.1 By Source
5.2 By Matrix
5.3 By Application
5.4 By End User
5.5 By Region
6. North America Market Size and Forecast
6.1 By Source
6.2 By Matrix
6.3 By Application
6.4 By End User
6.5 By Country
6.5.1 U.S. Market Size and Forecast
22.214.171.124 By source
126.96.36.199 By matrix
188.8.131.52 By application
184.108.40.206 By end user
6.5.2 Canada Market Size and Forecast
220.127.116.11 By source
18.104.22.168 By matrix
22.214.171.124 By application
126.96.36.199 By end user
7. Europe Market Size and Forecast
8. APAC Market Size and Forecast
9. LATAM Market Size and Forecast
10. MEA Market Size and Forecast
11. Competitive Landscape
11.1 Company Share Analysis
11.2 Product Benchmarking of Key Players
11.3 Strategic Developments of Key Players
11.3.3 Other Developments
12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/kcfmbm.